Gawaarida Shark

Qanacsan

• Waxay u egtahay inaysan waxtar u lahayn ...
• Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...
• Taxaddarrada gaarka ah & digniinta:

Gawaarida Shark (unug adag oo laastik ah oo bixiya taageero, sida lafta u sameyso) loo isticmaalo daawada waxay ka timaaddaa ugu horreyn shark lagu qabtay Badweynta Baasifigga. Noocyo dhowr ah oo soo saar ah ayaa laga sameeyaa carjawda shark oo ay ku jiraan squalamine lactate, AE-941, iyo U-995.

Carjawda Shark ayaa caan ku ah isticmaalka kansarka. Carjawda 'Shark' waxaa sidoo kale loo isticmaalaa cudurka 'osteoarthritis', cudurka 'psoriasis huurada', aragga la xiriira da'da lumis, bogsashada nabarrada, dhaawac soo gaara qaybta dambe ee isha sababo la xiriira sonkorowga, iyo caabuq ku dhaca xiidmaha (enteritis).

Dadka qaarkiis waxay si toos ah kilyaha 'shark carjawda' u marinayaan maqaarka si loo helo arthritis iyo cudurka psoriasis.

Dadka qaarkood waxay carjaw carjaw ah ka galaan malawadka malawadka kansarka.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee SHARK GAADIIDKA waa sida soo socota:

Waxay u egtahay inaysan waxtar u lahayn ...

• Kansarka. Cilmi baarista badankeedu waxay muujineysaa qaadashada carjawda shark afku inaysan wax u tareynin dadka qaba kansarka naasaha, xiidanka, sambabka, qanjirka 'prostate', ama maskaxda. Sidoo kale uma muuqato inay ka faa’iideysaneyso dadka qaba horumarsan, horay loo daaweeyay lugaha aan ahayn Hodgkin. Carjawda Shark looma baarin dadka qaba kansarka horumarsan.

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

• Buro ka soo baxda Kansarka oo loo yaqaan Kaposi sarcoma. Waxaa jira warbixino sheegaya in carjawda shark ee la mariyo maqaarka ay yareyn karto burooyinka loo yaqaan Kaposi sarcoma. Burooyinkaan waxay ku badan yihiin dadka qaba HIV.
• Cudurka Osteoarthritis. Markii la mariyo maqaarka, alaabada ay kujiraan carjawda shark oo ay weheliso waxyaabo kale ayaa lagu soo waramayaa inay yareynayaan astaamaha xanuunka Si kastaba ha noqotee, astaamaha astaamaynta waxay u badan tahay inay sabab u tahay maaddada kaafuur ee ma ahan maaddooyinka kale. Intaa waxaa sii dheer, ma jiraan wax cilmi baaris ah oo muujinaya in carjawda jilicsan ee loo yaqaan 'sharkla carjaw' ay maqaarka ka nuugto.
• Cudurka psoriasis. Cilmibaaris hore oo lagu sameeyay dadka cudurka psoriasis huurada leh waxay muujineysaa in soosaarida carjawda gaar ahaaneed (AE-941) ay wanaajineyso muuqaalka huurada waxayna yareysaa cuncunka markii afka laga qaadayo ama maqaarka la marinayo.
• Nooc ka mid ah kansarka kelyaha ee loo yaqaan 'renal cell carcinoma'. Qaadashada wax soo saar carjawda gaar ahaan (AE-941) ee afka ayaa kordhin karta badbaadada bukaanka qaba unugyada kansarka kalyaha.
• Aragti lumis la xiriirta da'da.
• Bogsashada nabarrada.
• Xaaladaha kale.

Cadeymo dheeri ah ayaa loobaahanyahay si loogu qiimeeyo carjawda shark ee adeegsigaan.

Carjawda Shark ayaa laga yaabaa inay ka hortagto koritaanka xididdada dhiigga ee cusub ee loo baahan yahay si kansarku u koro. Waxay sidoo kale ka hortagi kartaa koritaanka xididdada dhiigga ee nabarrada cudurka psoriasis. Tani waxay kaa caawin kartaa bogsiinta nabarradan.

Carjawda Shark waa BADBAADO KU SAABSAN dadka badankood marka afka la galiyo ilaa 40 bilood ama marka la mariyo maqaarka illaa 8 toddobaad.

Waxay u keeni kartaa dhadhan xun afka, lallabbo, matag, calool xanuun, calool istaag, cadaadis dhiig oo hooseeya, dawakhaad, sonkorta dhiigga oo sarreysa, heerarka kaalshiyamka oo sarreeya, daciifnimo, iyo daal. Waxay kaloo sababi kartaa cillad xagga beerka ah. Wax soo saarka qaarkood waxay leeyihiin ur iyo dhadhan aan fiicnayn.

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Ma jiro macluumaad ku filan oo la isku halleyn karo oo ku saabsan badbaadada qaadista carjawda shark haddii aad uur leedahay ama aad naas nuujinayso. Joog dhinaca aaminka ah iskana ilaali isticmaalka.

"Cudurada iswada" sida sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), ama xaalado kale: Carjawda Shark waxay sababi kartaa nidaamka difaaca jirka inuu noqdo mid firfircoon. Tani waxay kordhin kartaa astaamaha cudurada isdifaaca jirka. Haddii aad leedahay mid ka mid ah xaaladahaas, waxaa fiican inaad iska ilaaliso isticmaalka carjawda shark.

Heerarka sare ee kalsiyum (hypercalcemia): Carjawda 'Shark' ayaa laga yaabaa inay kordhiso heerarka kaalshiyamka, sidaa darteed waa inaysan u adeegsan dadka ay heerarkooda kaalshiyamku ay aad u sarreeyaan.

Dhexdhexaad

Ka taxaddar isku-dhafkan.

Daawooyinka yareeya nidaamka difaaca jirka (Immunosuppressants)

Carjawda Shark ayaa kordhin karta nidaamka difaaca jirka. Adoo kordhinaya nidaamka difaaca jirka, kilyaha 'shark carjawda' ayaa yareyn kara waxtarka daawooyinka yareeya nidaamka difaaca jirka.

Daawooyinka qaar ee yareeya nidaamka difaaca jirka waxaa ka mid ah azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK50) ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), iyo kuwa kale.

Kaalshiyamka

Gawaarida Shark ayaa kor u qaadi kara heerarka kaalshiyamka. Waxaa jira walaac ah in isticmaalkeeda oo ay weheliso kaalshiyamka laga yaabo inay ka dhigto heerarka kaalshiyamka inay aad u sarreeyaan.

Casiirka khudradda

Casiirka miraha aashitada leh sida oranjiga, tufaaxa, cinabka, ama yaanyada, wuxuu hoos u dhigi karaa awoodda carjawda shark markay daqiiqaduhu dhaafaan. Haddii carjawda shark lagu daro dheecaanka miraha, waa in lagu daro isla marka la isticmaalo ka hor.

Qiyaasta ku habboon ee carjawda shark waxay kuxirantahay dhowr arrimood sida da'da isticmaalaha, caafimaadka, iyo xaalado kale oo dhowr ah. Waqtigaan ma jiro macluumaad cilmi ku filan oo lagu go'aamin karo qiyaasta ugu habboon ee loo yaqaan 'carjawda' carjawda. Maskaxda ku hay in badeecooyinka dabiiciga ahi had iyo jeer aysan daruuri ahayn inay aamin yihiin oo qiyaasta ay muhiim noqon karto. Hubso inaad raacdo tilmaamaha ku habboon calaamadaha sheyga oo aad la tashato farmashiistahaaga ama takhtarkaaga ama xirfadlaha kale ee daryeelka caafimaadka ka hor intaadan isticmaalin.

AE-941, Cartilage de Requin, Cartilage de Requin du Pacifique, Cartilago de Tiburon, Collagène Marin, Extrait de Cartilage de Requin, Liquide de Cartilage Marin, Marine Collagen, Cartalage Marine Liquid, MSI-1256F, Neovastat, Pacific Shark Cartige, de Cartilage de Requin, Shark Cartilage Powder, Shark Cartilage Extract, Sphyrna lewini, Squalus acanthias.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.

1. Merly L, Smith SL. Waxyaabaha ku-oolka ah ee ka-hortagga carjawda. Immunopharmacol Immunotoxicol. 2015; 37: 140-7. Eeg aragti
2. Sakai S, Otake E, Toida T, Goda Y. Aqoonsiga asalka ah chondroitin sulfate ee "cuntooyinka caafimaadka". Chem Pharm Bull (Tokyo). 2007; 55: 299-303. Eeg aragti
3. PDQ Isuduwaha, Kala Beddelka, iyo Daaweynta Dheeraadka ah ee Tifaftirka. Jilbaha (Bovine iyo Shark) (PDQ®): Nooca Xirfadlaha Caafimaadka. Soo Koobidda Macluumaadka Kansarka ee PDQ [Internet]. Bethesda (MD): Machadka Kansarka Qaranka (US); 2002. 2016 Jul 21. Fiiri aragti aan la taaban karin.
4. Goldman E. Shark carjawda carjawda waxay isku dayday sidii daaweyn cudurka psoriasis ah. Maqaarka All News 1998; 29: 14.
5. Maamulka Cuntada iyo Dawooyinka. FDA waxay tallaabo ka qaadeysaa suuq geynta dawooyinka aan la ansixin. Warqadda hadalka ee FDA (Diisambar 10, 1999)
6. Lane W iyo Milner M. Isbarbardhig carjawda shark iyo carjawda xayawaanka. Townsend Lett 1996; 153: 40-42.
7. Zhuang, L, Wang, B, Shivji, G, iyo et al. AE-941, oo ah sheeko-joojiye cusub oo anjiogenesis ah ayaa saameyn weyn ku leh anti-bararka ku dhaca xasaasiyadda xiriirka. J Maalgelinta Derm 1997; 108: 633.
8. Turcotte P. Phase I qiyaasta daraasadda sii kordheysa ee AE-941, oo ah wakiil antiangiogenic, oo ku saabsan da'da bukaanka cillad maskaxeed. Shirka Beesha Retina (Hawaii, Diseembar 2, 1999).
9. Saunder DN. Angiogenesis antagonist sida daaweynta cudurka psoriasis: Natiijooyinka tijaabada caafimaad ee wajiga I ee AE-941. Shirka Akadeemiyada Mareykanka ee Shirka Cilmiga Caafimaadka, New Orleans, Louisiana, Maarso 19-24, 1999.
10. Aeterna Laboratories Inc. Wajiga III daraasad aan kala sooc lahayn oo lagu sameeyay AE-941 (Neovastat; Shark Cartilage Extract) ee bukaanada qaba unugyada kansarka kelyaha ee metastatic ee diidmada difaaca jirka. 2001.
11. Escudier, B, Patenaude, F, Bukowski, R, iyo et al. Sabab u ah wajiga III tijaabada bukaan socodka ee AE-941 (Neovastat (R)) ee bukaanjiifka unugyada kansarka kalyaha ah ee diidmada daaweynta jirka. Ann Oncol 2000; 11 (dheeri 4): 143-144.
12. Dupont E, Alaoui-Jamali M, Wang T, iyo et al. Waxqabadka Angiostatic iyo antitumoral ee AE-941 (Neovastat), jajabka moodeelka ee laga helo carjawda shark. Talaabooyinka Ururka Mareykanka ee Cilmi baarista Kansarka 1997; 38: 227.
13. Shimizu-Suganuma, Masum, Mwanatambwe, Milanga, Iida, Kazum, iyo et al. Saameynta carjawda shark ee koritaanka burooyinka iyo waqtiga noolaanshaha ee vivo (kulanka aan la taaban karin). Proc Annu Meet Am Soc Clin Oncol 1999; 18: A1760.
14. Qarsoodi. Waxqabadka Angiostatic iyo antitumoral ee AE-941 (neovastat-R), qayb jajaban oo laga soo qaatay carjawda 'shark' (kulanka aan la taaban karin). Pro Annu Kulan Am Assoc Kansarka Res 1997; 38: A1530.
15. Cataldi, JM iyo Osborne, DL. Saamaynta carjawda 'shark carjawda' ee ku saabsan neovascularization burooyinka naas-nuujinta iyo kordhinta unugyada ee vitro (kulanka aan la taaban karin). Joornaalka FASEB 1995; 9: A135.
16. Jamali MA, Riviere P, Falardeau A, iyo et al. Saamaynta AE-941 (Neovastat), anjiogenesis inhibitor ah, oo ku jirta Lewis sambabada kansarka nooca metastatic, waxtarka, ka hortagga sunta iyo badbaadada. Clin Invest Med 1998; (soo iibso): S16.
17. Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, iyo Dupont E. Tijaabada Wajiga I / II ee AE-941 (Neovastat) ee bukaanada qaba kansarka qanjirka 'prostate' (bandhig aan caadi ahayn). Shirka Sannadlaha ah ee Ururka Urolojiga ee Kanada (Juun 24-27, 2001).
18. Rosenbluth, RJ, Jennis, AA, Cantwell, S, iyo et al. Carjawda afka ee loo yaqaan 'carjawda afka' ee loo yaqaan 'shark carjawda' ee lagu daaweeyo bukaannada qaba burooyinka maskaxda ee aasaasiga ah. Daraasad tijaabo ah oo wajiga II ah (kulan aan caadi ahayn). Proc Annu Meet Am Soc Clin Oncol 1999; 18: A554.
19. Dupont E, Savard RE, Jourdain C, Juneau C, Thibodeau A, Ross N, iyo et al. Astaamaha antiangiogenic ee sheeko xariirta carjawda shark: doorka ka iman kara daaweynta cudurka psoriasis. J Cutan Med Surg 1998; 2: 146-152.
20. Lane IW iyo Contreras E. Heerka sare ee bioactivity (hoos u dhaca cabirka guud ee burooyinka) oo lagu arkay bukaanada kansarka sareeya ee lagu daaweeyay walxaha carjawda shark. J Naturopath Med 1992; 3: 86-88.
21. Wilson JL. Gawaarida jilicsan ee loo yaqaan 'shark shark' ayaa hoos u dhigta cudurka psoriasis. Comp Comp Ther 2000; 6: 291.
22. Riviere M, Latreille J, iyo Falardeau P. AE-941 (Neovastat), ka-hortagga angiogenesis: natiijooyinka tijaabada bukaan-socodka kansarka I / II. Kansarka Invest 1999; 17 (alaabta 1): 16-17.
23. Milner M. Tilmaamaha isticmaalka kilyaha shark ee daaweynta arthritis-ka iyo cudurrada kale ee wadajirka ah ee caabuqa. Amer Chiropractor 1999; 21: 40-42.
24. Leitner SP, Rothkopf MM, Haverstick DD, iyo et al. Laba daraasad oo ah daraasad laba weji ah oo ku saabsan budada carjawda afka qalalan (SCP) ee bukaannada qaba naaska metastatic ama kansarka qanjirka 'prostate' oo loo diido daaweynta caadiga ah. Amer Soc Clin Oncol 1998; 17: A240.
25. Evans WK, Latreille J, Batist G, iyo et al. AE-941, kahortaga angiogenesis: caqli gal u ah horumarka oo ay weheliso induction chemotherapy / radiotherapy ee bukaanada qaba kansarka sanbabada ee unugyada yar-yar (NSCLC). Waraaqo la macaashay 1999; S250.
26. Riviere M, Falardeau P, Latreille J, iyo et al. Natiijooyinka tijaabada caafimaad ee kansarka sanbabada wejiga I / II wuxuu la yimaadaa AE-941 (Neovastat ®) kahortaga cudurka angiogenesis. Clin Invest Med (dheeri) 1998; S14.
27. Riviere M, Alaoui-Jamali M, Falardeau P, iyo et al. Neovastat: kahortaga angiogenesis oo leh firfircoonida kansarka. Pro Amer Assoc Kansarka Kansarka 1998; 39: 46.
28. Qorayaashu ma jiraan. Navastat tijaabinta tijaabada caafimaadka. 2001;
29. Daraasadda Aeterna Laboratories Inc. Wajiga II ee daraasadda AE-941 (Neovastat; Shark Cartilage) ee bukaannada qaba soo-kabashada hore ama diidmada myeloma badan. 2001. Lambarka Xiriirka Macluumaadka 1-888-349-3232.
30. Felzenszwalb, I., Pelielo de Mattos, J. C., Bernardo-Filho, M., iyo Caldeira-de-Araujo, A. Shark carjawda carjawda leh: kahortaga noocyada oksijiinta firfircoon. Cuntada Chem Toxicol 1998; 36: 1079-1084. Eeg aragti
31. Coppes, M. J., Anderson, R. A., Egeler, R. M., iyo Wolff, J. E. Daaweynta kale ee daaweynta kansarka carruurnimada. N Engl. J Med 9-17-1998; 339: 846-847. Eeg aragti
32. Davis, P. F., He, Y., Furneaux, R. H., Johnston, P. S., Ruger, B. M., iyo Slim, G. C. Ka hortagga angiogenesis iyadoo la adeegsanayo afka oo la cuno carjawda budada ah ee budada ah ee qaabka jiirka. Microvasc.Res 1997; 54: 178-182. Eeg aragti
33. McGuire, T. R., Kazakoff, P. W., Hoie, E. B., iyo Fienhold, M. A. Waxqabadka antiproliferative ee carjawda shark oo leh oo aan lahayn buro necrosis factor-alpha oo ku jirta xididka xididka xididada aadanaha. Farmasiga daaweynta 1996; 16: 237-244. Eeg aragti
34. Kuettner, K. E. iyo Pauli, B. U. Ka hortagga neovascularization ee qodobka carjawda. Ciba waa la helay. 1983; 100: 163-173.Eeg aragti
35. Lee, A. iyo Langer, R. Shark carjawda waxaa ku jira ka hortagayaasha cudurka anjiogenesis. Sayniska 9-16-1983; 221: 1185-1187. Eeg aragti
36. Korman, D. B. [Antiangiogenic and antitumor properties of cartilage]. Vopr.Onkol. 2012; 58: 717-726. Eeg aragti
37. Patra, D. iyo Sandell, L. J. Antiangiogenic iyo moleculeellada lidka ku ah carjawda. Khabiir. Rev. Mol.Med 2012; 14: e10. Eeg aragti
38. de Mejia, E. G. iyo Dia, V. P. Doorka borotiinka nafaqada iyo peptides ee apoptosis, angiogenesis, iyo metastasis ee unugyada kansarka. Kansarka Metastasis Rev 2010; 29: 511-528. Eeg aragti
39. Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., iyo Safari, E. Saamaynta carjawda carjawda 'shark cartilage' ee laga helo unugyada NK. Immunopharmacol.Immunotoxicol. 2011; 33: 403-409. Eeg aragti
40. Lee, S. Y. iyo Chung, S. M. Neovastat (AE-941) wuxuu xakameynayaa bararka marin-haweedka iyada oo loo marayo VEGF iyo HIF-2 xakamaynta alfa. Vascul. Pharmacol 2007; 47 (5-6): 313-318. Eeg aragti
41. Pearson, W., Orth, M. W., Karrow, N. A., Maclusky, N. J., and Lindinger, M. I. Anti-bararka iyo saamaynta chondroprotective ee nafaqada ee Sasha's Blend ee qaabka cartilage ee sharraxa caabuqa. Mol Nutr Cuntada Res 2007; 51: 1020-1030. Eeg aragti
42. Kim, S., de, A., V, Bouajila, J., Dias, AG, Cyrino, FZ, Bouskela, E., Costa, PR, iyo Nepveu, F. Alpha-phenyl-N-tert-butyl nitrone ( PBN) derivatives: isku-dhafid iyo ficil difaac ah oo ka dhan ah waxyeelada microvascular ee ay keento ischemia / reperfusion. Bioorg.Med Chem 5-15-2007; 15: 3572-3578. Eeg aragti
43. Merly, L., Simjee, S., iyo Smith, S. L. Soo-saarista cytokines caabuq leh oo laga helo carjawda carjawda. Int Immunopharmacol. 2007; 7: 383-391. Eeg aragti
44. Moses, M. A., Sudhalter, J., iyo Langer, R. Aqoonsiga ka-hortagga neovascularization ka carjawda. Sayniska 6-15-1990; 248: 1408-1410. Eeg aragti
45. Ratel, D., Glazier, G., Provencal, M., Boivin, D., Beaulieu, E., Gingras, D., iyo Beliveau, R. enzymes-ka fibrinolytic oo si toos ah ushaqeynaya kana soosaaray carjawda carjawda: doorka daweynta ee suurtogalka ah cilado. Thromb .Res. 2005; 115 (1-2): 143-152. Eeg aragti
46. Gingras, D., Labelle, D., Nyalendo, C., Boivin, D., Demeule, M., Barthomeuf, C., iyo Beliveau, R. Wakiilka antiangiogenic Neovastat (AE-941) wuxuu kiciyaa waxqabadka unugyada firfircoonida plasminogen. Maalgeli Dawooyinka Cusub 2004; 22: 17-26. Eeg aragti
47. Latreille, J., Batist, G., Laberge, F., Champagne, P., Croteau, D., Falardeau, P., Levinton, C., Hariton, C., Evans, WK, iyo Dupont, E. Phase Tijaabada I / II ee badbaadada iyo waxtarka AE-941 (Neovastat) ee daaweynta kansarka sanbabada ee unugyada yar. Kansarka Sambabka Sanbab 2003; 4: 231-236. Eeg aragti
48. Bukowski, R. M. AE-941, oo ah xarun ka hortag ah antiangiogenic: tijaabooyinka kansarka unugyada kelyaha. Khabiir Opin Investig Dawooyinka 2003; 12: 1403-1411. Eeg aragti
49. Jagannath, S., Champagne, P., Hariton, C., iyo Dupont, E. Neovastat ee myeloma badan. Eur.J.Haematol. 2003; 70: 267-268. Eeg aragti
50. FDA waxay siisaa xaalad-agoon-daawo Aeterna's Neovastat oo loogu talagalay kansarka kalyaha. Khabiir. Rev. Anticancer Ther 2002; 2: 618. Eeg aragti
51. Dupont, E., Falardeau, P., Mousa, SA, Dimitriadou, V., Pepin, MC, Wang, T., iyo Alaoui-Jamali, MA Antiangiogenic iyo antimetastatic guryaha Neovastat (AE-941), oo ah soosaar afka ah oo firfircoon laga soo qaatay unugyada carjawda. Clin Exp Metastasis 2002; 19: 145-153. Eeg aragti
52. Beliveau, R., Gingras, D., Kruger, EA, Lamy, S., Sirois, P., Simard, B., Sirois, MG, Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, MC, Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, WD, iyo Dupont, E. Wakiilka Antiangiogenic Neovastat (AE-941) Wuxuu Mamnuucayaa Isirka Koritaanka Vascular Endothelial -saamaynta Cilmiga Biyoolajiga. Kiliniga Kansarka 2002; 8: 1242-1250. Eeg aragti
53. Weber, M. H., Lee, J., iyo Orr, F. W. Saameynta Neovastat (AE-941) ee qaabka burooyinka lafaha metastatic ee tijaabada ah. Int J Oncol 2002; 20: 299-303. Eeg aragti
54. Barber, R., Delahunt, B., Grebe, S. K., Davis, P. F., Thornton, A., iyo Slim, G. C. Gawaarida afka ee sharkku ma baabi'iyo kansarka laakiin waxay dib u dhigeysaa horumarka burooyinka ee qaabka murunka. Anticancer Res 2001; 21 (2A): 1065-1069. Eeg aragti
55. Gonzalez, RP, Soares, FS, Farias, RF, Pessoa, C., Leyva, A., Barros Viana, GS, iyo Moraes, MO Bandhigga saameynta xaddidan ee carjawda afka ee ku saabsan koritaanka fibroblast ee cunsuriyada asaasiga ah ee keena angiogenesis ee bakaylaha kiliyaha. Biol.Pharm.Bull. 2001; 24: 151-154. Eeg aragti
56. Brem, H. iyo Folkman, J. Ka hortagga burooyinka angiogenesis oo ay dhexdhexaadiso carjawda. J Exp.Med 2-1-1975; 141: 427-439. Eeg aragti
57. Koch, A. E. Doorka angiogenesis ee rheumatoid arthritis: horumarkii ugu dambeeyay. Ann Rheum. 2000; 59 Qalabka 1: i65-i71. Eeg aragti
58. Wadahadalada, K. L. iyo Harris, A. L. Xaaladda hadda jirta ee isirrada antiangiogenic. Br J Haematol. 2000; 109: 477-489. Eeg aragti
59. Morris, G. M., Coderre, J. A., Micca, P. L., Lombardo, D. T., iyo Hopewell, J. W. Boron daaweynta qabashada neerfaha ee jiirka 9L gliosarcoma: qiimeynta saameynta carjawda shark. Br J Radiol. 2000; 73: 429-434. Eeg aragti
60. Renckens, C. N. iyo van Dam, F. S. [Sanduuqa kansarka qaranka (Koningin Wilhelmina Fonds) iyo Houtsmuller-therapy for kansarka]. Ned.Tijdschr.Geneeskd. 7-3-1999; 143: 1431-1433. Eeg aragti
61. Moses, MA, Wiederschain, D., Wu, I., Fernandez, CA, Ghazizadeh, V., Lane, WS, Flynn, E., Sytkowski, A., Tao, T., and Langer, R. Troponin I waa oo ku jira carjawda aadanaha waxayna xakameysaa angiogenesis. Proc Natl.Acad.Sci USA 3-16-1999; 96: 2645-2650. Eeg aragti
62. Moller HJ, Moller-Pedersen T, Damsgaard TE, Poulsen JH. Muujinta keratin sulphate immunogenic ee ganacsiga chondroitin 6-sulfate oo ka socda carjawda shark. Saamaynta tijaabooyinka ELISA. Sharciga 'Chim Acta' 1995; 236: 195-204. Eeg aragti
63. Lu C, Lee JJ, Komaki R, iyo al. Chemoradiotherapy oo leh ama aan lahayn AE-941 marxaladda III kansarka sanbabada ee unugyada aan yareyn: tijaabada wajiga III ee tijaabada ah. J Natl Kansarka Inst 2010; 102: 1-7. Eeg aragti
64. Loprinzi CL, Levitt R, Barton DL, iyo al. Qiimeynta carjawda shark ee bukaanka qaba kansarka daran: tijaabada Kooxda Daaweynta Kansarka Waqooyiga Dhexe. Kansarka 2005; 104: 176-82. Eeg aragti
65. Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) ee bukaanka carcinoma kelyaha ee kelyaha ah: warbixinta tijaabada wajiga II oo leh laba heer oo qiyaaso ah. Ann Oncol 2002; 13: 1259-63 .. Arag soo koob.
66. Sauder DN, Dekoven J, Champagne P, iyo al. Neovastat (AE-941), kahortaga cudurka anjiogenesis: wajiga isdabamarin ee tijaabada bukaan socodka I / II wuxuu keenaa bukaanada qaba cudurka psoriasis. J Am Acad Dermatol 2002; 47: 535-41. Eeg aragti
67. Gingras D, Renaud A, Mousseau N, iyo al. Ka-hortagga Matrix protein-ka ee AE-941, oo ah dhisme ka hortagga antiangiogenic. Anticancer Res 2001; 21: 145-55 .. Arag soo koob.
68. Falardeau P, Champagne P, Poyet P, et al. Neovastat, oo ah daawo si dabiici ah u shaqeysa antiangiogenic, marxaladda III tijaabooyinka bukaan socodka. Semin Oncol 2001; 28: 620-5 .. Eeg duluc.
69. Boivin D, Gendron S, Beaulieu E, et al. Wakiilka antiangiogenic Neovastat (AE-941) wuxuu kiciyaa apoptosis cell endothelial. Mol Cancer Ther 2002; 1: 795-802 .. Aragtida la soo koobay.
70. Cohen M, Wolfe R, Mai T, Lewis D. Waa la kala soocay, indhoole labalaab ah, tijaabinta placebo ee kareem la mariyo oo ay kujiraan glycosamine sulfate, chondroitin sulfate, iyo kaafuur osteoarthritis ee jilibka. J Rheumatol 2003; 30: 523-8 .. Eeg aragti aan la taaban karin.
71. May B, Kuntz HD, Kieser M, Kohler S. Wax ku oolnimada saliida peppermint go'an / isku darka saliida caraway ee dyspepsia non-ulcer. Arzneimittelforschung 1996; 46: 1149-53. Eeg aragti
72. Anon. AEterna waxay ku dhawaaqeysaa bilowga isdiiwaangalinta bukaanka ee NIH - oo ay kafaala qaaday wajiga III tijaabada bukaan socodka ee AE-941 / Neovastat ee daaweynta kansarka sanbabada. Soosaarida News Aeterna 2000 2000 May 17.
73. Sheu JR, Fu CC, Tsai ML, Chung WJ. Saamaynta U-995, carjawda kartilage xoog leh ee ka soo baxda angiogenesis, oo ku saabsan hawlaha anti-angiogenesis iyo ka hortagga burooyinka. Anticancer Res 1998; 18: 4435-41. Eeg aragti
74. Fontenele JB, Viana GS, Xavier-Filho J, de-Alencar JW. Waxqabadka anti-bararka iyo xanuunka ee qayb ka mid ah biyo-ku milma carjawda shark. Braz J Med Biol Qaraarka 1996; 29: 643-6. Eeg aragti
75. Fontenele JB, Araujo GB, de Alencar JW, Viana GS. Dhibaatooyinka xanuunka iyo anti-bararka ee carjawda shark waxay sabab u tahay maadada peptide waxayna ku tiirsan tahay nidaamka nitric oxide (MAYA). Biol Pharm Bull 1997; 20: 1151-4. Eeg aragti
76. Gomes EM, Souto PR, Felzenszwalb I. Shark-carjawda oo ay ku jirto diyaarintu waxay ka ilaalisaa unugyada ka hortagga dhaawaca iyo mutagenesis. Mutat Res 1996; 367: 204-8. Eeg aragti
77. Mathews J. Warbaahintu waxay si waalli ah u quudisaa carjawda 'shark' sida daaweynta kansarka. J Natl Kansarka Inst 1993; 85: 1190-1. Eeg aragti
78. Bhargava P, Trocky N, Marshall J, et al. Badbaadada wajiga 1aad, dulqaadka iyo daraasada dawooyinka farmasokokinikada ee qiyaasta sii kordheysa, sii kordheysa mudada soo socota ee faleebada MSI-1256F (Squalamine Lactate) ee bukaanada qaba kansarka horumarsan. Proc Am Soc Clinical Oncol 1999; 18: A698.
79. Kalidas M, Hammond LA, Patnaik P, et al. Darajada I iyo farmashiyaha (PK) ee daraasadda angiogenesis inhibitor, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 2000; 19: A698.
80. Patnaik A, Rowinsky E, Hammond L, et al. Darajada I iyo farmashiyaha (PK) ee daraasadda ee gaarka u ah angiogenesis inhibitor, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 1999; 18: A622.
81. Evans WK, Latreille J, Batist G, iyo al. AE-941, kahortaga cudurka angiogenesis: caqli gal u ah horumarka oo ay weheliso induction chemotherapy / radiotherapy ee bukaanada qaba kansarka sanbabada ee unugyada yar (NSCLC). Proc Am Soc Clinical Oncol 1999; 18: A1938.
82. Rosenbluth RJ, Jennis AA, Cantwell S, DeVries J. Oral shark cartilage ee daaweynta bukaannada qaba burooyinka maskaxda ee aasaasiga ah. Daraasad tijaabo ah oo wajiga II ah. Proc Am Soc Clinical Oncol 1999; 18: A554.
83. Leitner SP, Rothkopf MM, Haverstick L, iyo al. Laba daraasadood oo daraasad ah oo ku saabsan budada carjawda afka qalalan (SCP) ee bukaannada (pts) oo leh naas metastatic ama kansarka qanjirka 'prostate' oo loo diido daaweynta caadiga ah. Proc Am Soc Clinical Oncol 1998; 17: A240.
84. Machadka Kansarka Natl CancerNet. Cartilage website: www.cancer.gov (La Galay 18 Ogosto 2000).
85. Berbari P, Thibodeau A, Germain L, et al Saamaynta antiangiogenic ee maamulka afka ee soosaarida carjawda dareeraha ah ee aadanaha. J Surg Qaraarka 1999; 87: 108-13. Eeg aragti
86. Hillman JD, Peng AT, Gilliam AC, Remick SC. Daaweynta Kaposi Sarcoma iyadoo la adeegsanayo maamulka afka ee carjawda 'shark carjawda' ee fayraska 'Herpes' ee fayraska '8-seropositive, Human Immunodeficiency Virus-Seronegative' khaniis. Arch Dermatol 2001; 137: 1149-52. Eeg aragti
87. Navastat tijaabinta tijaabada caafimaadka. Lagu soo bandhigay Ururka Cilmi-baarista Kansarka ee Mareykanka kulankiisii ​​sanadlaha ee 92aad. 27-Mar-2001.
88. Wilson JL. Gawaarida jilicsan ee loo yaqaan 'shark shark' ayaa ka adkaata cudurka psoriasis: dib u eegista cilmi baarista iyo natiijooyinka caafimaad ee hordhaca ah. Beddel Dheeraad ah 2000; 6: 291.
89. Miller DR, Anderson GT, Stark JJ, iyo al. Tijaabada Wejiga I / II ee amniga iyo waxtarka carjawda shark ee daaweynta kansarka horumarsan. J Clin Oncol 1998; 16: 3649-55. Eeg aragti
90. Lane IW, Comac L. Sharks kuma dhaco kansar. Garden City, NY: Kooxda daabacaadda ee Avery; 1992.
91. Hunt TJ, Connelly JF. Carjawda Shark ee daaweynta kansarka. Am J Caafimaadka Syst Pharm 1995; 52: 1756-60. Eeg aragti
92. Ashar B, Vargo E. Cudurka cagaarshowga ee ku dhaca carjawda 'carjawda' [warqad]. Ann Intern Med 1996; 125: 780-1. Eeg aragti

Markii ugu dambeysay ee dib loo eegay - 03/14/2019